Objectives. To clarify cognitive impairments in adults with attention deficit hyperactivity syndrome (ADHD) and to assess the efficacy of the formulation Memoplant in the treatment of this pathology. Materials and Methods. The results of clinical, psychological, and electroencephalographic studies of 40 patients aged 18–45 years with ADHD are presented. From recruitment into the study, all patients received Memoplant at a daily dose of 240 mg for eight weeks. Results and conclusions. Adult patients with ADHD had both subjective and objective impairments to memory and attention. EEG results suggested that patients showed dysfunction of the frontothalamic regulatory system and deficit of nonspecific activation by the reticular formation. Courses of Memoplant were followed by clinical improvements in 24 patients (60.0%). Repeat psychological and neurophysiological studies demonstrated decreases in attention deficit and improvements in memory measures.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
G. Polanczyk, M. S. de Lima, B. L. Horta, J. Biederman, and L. A. Rohde, “The worldwide prevalence of ADHD: a systematic review and metaregression analysis,” Am. J. Psychiatry, 164, No. 6, 942–948 (2007), doi: https://doi.org/10.1176/ajp.2007.164.6.942.
P. Rao and M. Place, “Prevalence of ADHD in four general adult outpatient clinics in North East England,” Prog. Neurol. Psychiatry, 15, No. 5, 7–10 (2011), doi: https://doi.org/10.1002/pnp.211.
E. G. Willcutt, “The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review,” Neurotherapeutics, 9, No. 3, 490–499 (2012), doi: https://doi.org/10.1007/s13311-012-0135-8.
J. Fayyad, N. A. Sampson, I. Hwang, et al., “The descriptive epidemiology of DSM-IV adult ADHD in the World Health Organization World Mental Health Surveys,” Atten. Defic. Hyperact. Disord., 19, 1–19 (2016), doi: https://doi.org/10.1007/s12402-016-0208-3.
I. T. Nureev, M. V. Zlokazova, and V. I. Tsirkin, “Experience in the use of the ASRS V1.1 questionnaire scales for the diagnosis of attention deficit hyperactivity disorder in adults,” Vestn. Pomorsk. Univ. Ser. Giziol. Psychol.-Pedagog. Nauk., 4, 98–102 (2007).
T. Archer, M. Oscar-Berman, and K. Blum, “Epigenetics in developmental disorder: ADHD and endophenotypes,” J. Genet. Syndr. Gene Ther., 2, No. 1, 100–104 (2011), doi: https://doi.org/10.4172/2157-7412.1000104.
E. Murray, R. Pearson, M. Fernandes, I. S. Santos, F. C. Barros, C. G. Victora, A. Stein, and A. Matijasevich, “Are fetal growth impairment and preterm birth causally related to child attention problems and ADHD? Evidence from a comparison between high-income and middle-income cohorts,” J. Epidemiol. Community Health, 70, No. 7, 704–709 (2016), doi: https://doi.org/10.1136/jech-2015-206222.
O. R. Nogovitsina and E. V. Levitina, “Effects of perinatal risk factors on the formation of attention deficit hyperactivity disorder in children,” Ross. Vestn. Perinatol. Pediatr., 1, 64–65 (2012).
S. V. Faraone and S. A. Khan, “Candidate gene studies of attention-deficit/hyperactivity disorder,” J. Clin. Psychiatry, 67, No. 8, 13–20 (2006).
B. N. Kim, J. W. Kim, and H. Kang, “Regional differences in cerebral perfusion associated with the alpha-2A-adrenergic receptor genotypes in attention deficit hyperactivity disorder,” J. Psychiatr. Neurosci., 35, No. 5, 330–336 (2010), doi: https://doi.org/10.1503/jpn.090168.
K. Ding, J. Yang, G. P. Reynolds, B. Chen, J. Shao, R. Liu, Q. Qian, H. Liu, R. Yang, J. Wen, and C. Kang, “DAT1 methylation is associated with methylphenidate response on oppositional and hyperactive-impulsive symptoms in children and adolescents with ADHD,” World J. Biol. Psychiatry, 27, 1–9 (2016), doi: https://doi.org/10.1080/15622975.2016.1224928.
R. M. Alderson, L. J. Kasper, K. L. Hudec, and C. H. Patros, “Attention-deficit/hyperactivity disorder (ADHD) and working memory in adults: a meta-analytic review,” Neuropsychology, 27, No. 3, 287–302 (2013), doi: https://doi.org/10.1037/a0032371.
R. N. Elisa, E. Balaguer-Ballester, and B. A. Parris, “Inattention, working memory, and goal neglect in a community sample,” Front. Psychol., 7, 1428 (2016), doi: https://doi.org/10.3389/fpsyg.2016.01428.
K. Murphy, R. Barkley, and T. Bush, “Young adults with attention deficit hyperactivity disorder: subtype differences in comorbidity, educational, and clinical history,” J. Nerv. Ment. Dis., 190, 147–157 (2002), doi: https://doi.org/10.1097/00005053-200203000-00003.
R. C. Kessler, L. A. Adler, M. J. Gruber, C. A. Sarawate, T. Spencer, and D. L. Van Brunt, “Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) screener in a representative sample of health plan members,” Int. J. Met. Psych. Res., 16, No. 2, 52–65 (2007), doi: https://doi.org/10.1002/mpr.208.
D. E. Broadbent, P. F. Cooper, P. FitzGerald, and K. R. Parkes, “The Cognitive Failures Questionnaire (CFQ) and its correlates,” Br. J. Clin. Psychol., 21, 1–16 (1982), doi: https://doi.org/10.1111/j.2044-8260.1982.tb01421.x.
Y. Luo, “Contemporary neuroscience meets traditional medicine – towards understanding Ginkgo biloba neuroprotection,” Curr. Top. Nutraceut. Res., 1, 49–58 (2003).
F. Tchantchou, P. N. Lacor, Z. Cao, et al., “Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons,” J. Alzheimers Dis., 18, No. 4, 787–798 (2009).
K. Schwanz, L. Palm, and S. Brallier, “Attention problems and hyperactivity as predictors of college grade point average,” J. Atten. Disord., 11, 368–373 (2007), doi: https://doi.org/10.1177/1087054707305155.
S. Blase, A. Gilbert, A. Anastopoulos, et al., “Self-reported ADHD and adjustment in college: cross-sectional and longitudinal findings,” J. Atten. Disord., 3, No. 13, 297–309 (2009), doi: https://doi.org/10.1177/1087054709334446.
R. G. Voigt, S. K. Katusic, R. C. Colligan, J. M. Killian, A. L. Weaver, and W. J. Barbaresi, “Academic achievement in adults with a history of childhood attention-deficit/hyperactivity disorder: A population-based prospective study,” J. Dev. Behav. Pediatr., 23, 1 (2016), doi: https://doi.org/10.1097/dbp.0000000000000358.
R. A. Barkley and M. Fischer, “Predicting impairment in major life activities and occupational functioning in hyperactive children as adults: self-reported executive function (EF) deficits versus EF tests,” Dev. Neuropsychol., 36, 137–161 (2011), doi: https://doi.org/10.1080/87565641.2010.549877.
V. A. Grane, T. Endestad, A. F. Pinto, and A. K. Solbakk, “Attentional control and subjective executive function in treatment-naive adults with attention deficit hyperactivity disorder,” PLoS One, 9, No. 12, 115227 (2014), doi: https://doi.org/10.1371/journal.pone.0115227.
T. Yoshitake, S. Yoshitake, and J. Kehr, “The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex,” Br. J. Pharmacol., 159, No. 3, 659–668 (2010), doi: https://doi.org/10.1111/j.1476-5381.2009.00580.x.
A. N. Boiko, A. V. Lebedeva, I. A. Shchukin, et al., “Potential of medication-based correction of moderate cognitive disorder,” Zh. Nevrol. Psikhiat., 2, 28–32 (2013).
I. V. Litvinenko, K. M. Naumov, and M. M. Odinak, “Correction of cognitive and noncognitive symptoms of cerebrovascular disease,” Zh. Nevrol. Psikhiat., 4, 35–40 (2014).
L. S. Chutko, S. Yu. Surushkina, A. V. Rozhkova, I. S. Nikishena, and E. A. Yakovenko, “Asthenic symptoms complex in patients with emotional burnout syndrome,” Zh. Nevrol. Psikhiat., No. 11, 22–26 (2013).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 117, No. 5, Iss. 1, pp. 9–13, May, 2017.
Rights and permissions
About this article
Cite this article
Chutko, L.S., Surushkina, S.Y., Yakovenko, E.A. et al. Diagnosis and Treatment of Cognitive Impairments in Attention Deficit Syndrome in Adults. Neurosci Behav Physi 49, 115–120 (2019). https://doi.org/10.1007/s11055-018-0703-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-018-0703-4